Description
ZHEJIANG RUIBANG LABORATORIES is a pharmaceutical manufacturer established in 1956, specialising in the production of Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing (CDMO) services. The company is well-regarded in the industry, holding approvals from the U.S. FDA and certifications for Chinese GMP and European GMP standards. Ruibang’s commitment to quality ensures that they deliver high-quality products, which include a range of APIs and gluconate series, at affordable prices.
Services include:
– APIs (Active Pharmaceutical Ingredients)
– Contract Development and Manufacturing (CDMO)
– Production of Cyclosporine, Mupirocin, Fusidic Acid, Polymycin B, Mlibemycin Oxime
– Gluconate series (calcium gluconate, zinc gluconate, magnesium gluconate, potassium, etc.)
ZHEJIANG RUIBANG LABORATORIES continues to strive for excellence in the pharmaceutical industry by offering high-quality products and services to its clients. For more information, visit china-ruibang.com.
Contact Information
Related Listings

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel










